FDA Target Dates Cluster for Five Biotech Companies Through Year-End
A commentary report says five drugmakers that issued quarterly results or pipeline updates from Oct. 29 to Nov. 9 have FDA target action dates in the final weeks of 2026.
A commentary report says five drugmakers that issued quarterly results or pipeline updates from Oct. 29 to Nov. 9 have FDA target action dates in the final weeks of 2026.